Inventor
PIXU LI
Inventor
CN
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds32%
C07CAcyclic or carbocyclic compounds21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
A61KPreparations for medical, dental or toiletry purposes11%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry5%
C07BGeneral methods of organic chemistry5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
Y02PClimate change mitigation technologies in the production or processing of goods5%
PatentTitleYear
12,221,413Processes to produce brivaracetam202512,091,414Crystalline form of Di-p-toluoyl-L-tartrate of upadacitinib202411,926,633Synthesis methods for upadacitinib and intermediate thereof202411,673,862Processes to produce brivaracetam202311,377,426Processes to produce elagolix202211,161,851Processes to produce acalabrutinib2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to SUZHOU PENGXU PHARMATECH CO LTD (6)· patent assignee history
2021–2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SUZHOU PENGXU PHARMATECH CO LTD | 6 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 6 | 2021–2025 |